Daniel Dixon has been appointed vice president of Quality Control, UPM Pharmaceuticals. Dixon will oversee UPM's Analytical Testing & Development groups and the Microbiological & Raw Material Testing Labs.
"Daniel brings a wealth of experience and enthusiasm to this key position at UPM. With his diverse experience in Research, Analytical Testing, Manufacturing and Quality Assurance, I am quite confident that Daniel will enhance and continue to grow our Quality Control Laboratory systems and Analytical capabilities," Chris Curtin, chief operating officer of UPM Pharmaceuticals said.
Dixon's experience includes diverse projects throughout the product lifecycle, research, manufacturing and quality assurance; holding advanced positions after serving in the U.S. Army Medical Division. This experience encompasses both pharmaceutical and medical device regulated testing and manufacture; and he is the co-inventor on six patents. Dixon also served in advanced QC/QA positions for Colgate Palmolive and Dentsply Sirona.